NRAS loss of heterozygosity (LOH) is rarely observed in human tumors and, consistent with prior reports34, we see that variant allele frequency (VAF) does not differ between NRAS codon 61 mutations that are rare or enriched in human melanoma (Supplementary Fig. 4). Here, NRAS is linked to melanoma.